Neuropsychopharmacology
Journal of Psychopharmacology
European Neuropsychopharmacology
Psychopharmacology
- Reduced cortical GABA and glutamate in high schizotypy4 years ago
- Adaptive aspects of impulsivity and interactions with effects of catecholaminergic agents in the 5-choice serial reaction time task: implications for ADHD4 years ago
- The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study4 years ago
- Resveratrol attenuates arsenic-induced cognitive deficits via modulation of Estrogen-NMDAR-BDNF signalling pathway in female mouse hippocampus4 years ago
- Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes4 years ago
- The GABAB receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats4 years ago
- A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice4 years ago
International Journal of Neuropsychopharmacology
Frontiers in Pharmacology
Translational Psychiatry
Molecular Psychiatry
Nature Reviews Neuroscience
CNS Spectrum
Neuropharmacology
Nature
- Europe must grasp chance to become a scientific powerhouse5 months ago
- Cells are swapping their mitochondria. What does this mean for our health?5 months ago
- Europe needs to step up on epidemic preparedness5 months ago
- Countries must consider their global footprint when using natural resources5 months ago
- ‘Now is not the time for despair’ — how scientists can take a stand against political interference5 months ago
- Asilomar conference took courage and foresight — today, inclusivity would also be crucial5 months ago
- Cannabis studies were informing fundamental neuroscience in the 1970s5 months ago